Jun‐Long Liang
Impact in
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 25
-
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 1
- Co-authors
- Xian‐Zheng Zhang (26 shared papers)Xiao‐Kang Jin (18 shared papers)Wei‐Hai Chen (14 shared papers)Shi‐Man Zhang (15 shared papers)Qian‐Xiao Huang (11 shared papers)Guo‐Feng Luo (5 shared papers)Mei‐Ting Niu (6 shared papers)Chuan‐Jun Liu (5 shared papers)
- Journals
- Advanced Materials (6 papers)Biomaterials (4 papers)ACS Nano (3 papers)Nano Today (3 papers)Nano Letters (3 papers)
- Partner nations
- China
In The Last Decade
Jun‐Long Liang
33 papers receiving 1.5k citations
Jun‐Long Liang's Hit Papers
Peers
Comparison fields: 5 of 66
- Biomedical Engineering 821
- Biomaterials 215
- Biotechnology 58
- Molecular Medicine 54
- Immunology 152
Countries citing papers authored by Jun‐Long Liang
This map shows the geographic impact of Jun‐Long Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Long Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Long Liang more than expected).
Fields of papers citing papers by Jun‐Long Liang
This network shows the impact of papers produced by Jun‐Long Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Long Liang. The network helps show where Jun‐Long Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Long Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 181 | |
| 2 | Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma Hit paper breakdown → | 2023 | 147 |
| 3 | 2023 | 126 | |
| 4 | 2023 | 125 | |
| 5 | 2016 | 113 | |
| 6 | 2023 | 83 | |
| 7 | 2018 | 64 | |
| 8 | 2024 | 61 | |
| 9 | 2023 | 53 | |
| 10 | 2023 | 49 | |
| 11 | 2019 | 44 | |
| 12 | 2024 | 44 | |
| 13 | 2023 | 37 | |
| 14 | 2020 | 36 | |
| 15 | 2019 | 31 | |
| 16 | 2023 | 30 | |
| 17 | 2024 | 30 | |
| 18 | 2020 | 24 | |
| 19 | 2024 | 23 | |
| 20 | 2024 | 21 |
About Jun‐Long Liang
Jun‐Long Liang is a scholar working on Biomedical Engineering, Immunology, Biotechnology, Oncology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Research and Treatments (3 papers), Adsorption and biosorption for pollutant removal (1 paper), RNA Interference and Gene Delivery (1 paper), Immune cells in cancer (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Biomedical Engineering (821 citations), Biomaterials (215 citations), Biotechnology (58 citations), Molecular Medicine (54 citations) and Immunology (152 citations). Jun‐Long Liang has collaborated with scholars based in China. Frequent co-authors include Xian‐Zheng Zhang, Xiao‐Kang Jin, Wei‐Hai Chen, Shi‐Man Zhang, Qian‐Xiao Huang, Guo‐Feng Luo, Mei‐Ting Niu, Chuan‐Jun Liu, Qi‐Wen Chen and Zhiwen Hu. Their work appears in journals such as Advanced Materials, Biomaterials, ACS Nano, Nano Today and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.